These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8589259)
1. Identification of a soluble, high affinity human interleukin 4 binding protein in normal human urine. Christie G; Dacey I; Weston BJ Cytokine; 1995 May; 7(4):305-10. PubMed ID: 8589259 [TBL] [Abstract][Full Text] [Related]
3. Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response. Leland P; Obiri N; Aggarwal BB; Puri RK Oncol Res; 1995; 7(5):227-35. PubMed ID: 8534928 [TBL] [Abstract][Full Text] [Related]
4. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential. Lauffer L; Kanzy EJ; Köhler R; Kurrle R; Enssle K; Seiler FR Behring Inst Mitt; 1995 Jun; (96):21-31. PubMed ID: 7575349 [TBL] [Abstract][Full Text] [Related]
5. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes. Jerva LF; Sullivan G; Lolis E Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277 [TBL] [Abstract][Full Text] [Related]
6. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. Blum H; Wolf M; Enssle K; Röllinghoff M; Gessner A J Immunol; 1996 Sep; 157(5):1846-53. PubMed ID: 8757301 [TBL] [Abstract][Full Text] [Related]
7. Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4. Ma Y; Hurst HE; Fernandez-Botran R J Pharmacol Exp Ther; 1996 Oct; 279(1):340-50. PubMed ID: 8859012 [TBL] [Abstract][Full Text] [Related]
8. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. Zhang JG; Hilton DJ; Willson TA; McFarlane C; Roberts BA; Moritz RL; Simpson RJ; Alexander WS; Metcalf D; Nicola NA J Biol Chem; 1997 Apr; 272(14):9474-80. PubMed ID: 9083087 [TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1. Mazzei GJ; Seckinger PL; Dayer JM; Shaw AR Eur J Immunol; 1990 Mar; 20(3):683-9. PubMed ID: 2138562 [TBL] [Abstract][Full Text] [Related]
10. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716 [TBL] [Abstract][Full Text] [Related]
11. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184 [TBL] [Abstract][Full Text] [Related]
12. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein. Shen BJ; Hage T; Sebald W Eur J Biochem; 1996 Aug; 240(1):252-61. PubMed ID: 8797861 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Serve H; Oelmann E; Herweg A; Oberberg D; Serve S; Reufi B; Mücke C; Minty A; Thiel E; Berdel WE Cancer Res; 1996 Aug; 56(15):3583-8. PubMed ID: 8758930 [TBL] [Abstract][Full Text] [Related]
15. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4. Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6. Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772 [TBL] [Abstract][Full Text] [Related]
17. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA. Oh JW; Revel M; Chebath J Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669 [TBL] [Abstract][Full Text] [Related]
18. [Cytokine binding proteins: a model of interleukin 6]. Brailly H; Montero-Julian FA Arch Inst Pasteur Tunis; 1994; 71(3-4):535-48. PubMed ID: 8801856 [No Abstract] [Full Text] [Related]
19. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding. Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599 [TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Müller-Newen G; Köhne C; Keul R; Hemmann U; Müller-Esterl W; Wijdenes J; Brakenhoff JP; Hart MH; Heinrich PC Eur J Biochem; 1996 Mar; 236(3):837-42. PubMed ID: 8665902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]